Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016 (2016), Article ID 3149243, 9 pages
http://dx.doi.org/10.1155/2016/3149243
Research Article

Elevated Omentin Serum Levels Predict Long-Term Survival in Critically Ill Patients

1Department of Internal Medicine III, University Clinic of Schleswig-Holstein, Schittenhelmstrasse 12, 24105 Kiel, Germany
2Department of Medicine III, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany

Received 17 July 2016; Revised 12 September 2016; Accepted 4 October 2016

Academic Editor: Andreas Hillenbrand

Copyright © 2016 Mark Luedde et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Ilias, D. A. Vassiliadi, M. Theodorakopoulou et al., “Adipose tissue lipolysis and circulating lipids in acute and subacute critical illness: Effects of shock and treatment,” Journal of Critical Care, vol. 29, no. 6, pp. 1130.e5–1130.e9, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Acharya, S. Navina, and V. P. Singh, “Role of pancreatic fat in the outcomes of pancreatitis,” Pancreatology, vol. 14, no. 5, pp. 403–408, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. S. J. Van Cromphaut, I. Vanhorebeek, and G. Van den Berghe, “Glucose metabolism and insulin resistance in sepsis,” Current Pharmaceutical Design, vol. 14, no. 19, pp. 1887–1899, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Koch, R. Weiskirchen, H. W. Zimmermann, E. Sanson, C. Trautwein, and F. Tacke, “Relevance of serum leptin and leptin-receptor concentrations in critically ill patients,” Mediators of Inflammation, vol. 2010, Article ID 473540, 9 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. B. K. Tan, R. Adya, and H. S. Randeva, “Omentin: a novel link between inflammation, diabesity, and cardiovascular disease,” Trends in Cardiovascular Medicine, vol. 20, no. 5, pp. 143–148, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Kazama, T. Usui, M. Okada, Y. Hara, and H. Yamawaki, “Omentin plays an anti-inflammatory role through inhibition of TNF-α-induced superoxide production in vascular smooth muscle cells,” European Journal of Pharmacology, vol. 686, no. 1–3, pp. 116–123, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. C. M. De Souza Batista, R.-Z. Yang, M.-J. Lee et al., “Omentin plasma levels and gene expression are decreased in obesity,” Diabetes, vol. 56, no. 6, pp. 1655–1661, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Lapointe, P. Poirier, J. Martin, M. Bastien, A. Auclair, and K. Cianflone, “Omentin changes following bariatric surgery and predictive links with biomarkers for risk of cardiovascular disease,” Cardiovascular Diabetology, vol. 13, no. 1, article 124, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Ohashi, R. Shibata, T. Murohara, and N. Ouchi, “Role of anti-inflammatory adipokines in obesity-related diseases,” Trends in Endocrinology and Metabolism, vol. 25, no. 7, pp. 348–355, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Carmina, “Obesity, adipokines and metabolic syndrome in polycystic ovary syndrome,” Frontiers of Hormone Research, vol. 40, pp. 40–50, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Herder, M. Carstensen, and D. M. Ouwens, “Anti-inflammatory cytokines and risk of type 2 diabetes,” Diabetes, Obesity and Metabolism, vol. 15, no. 3, pp. 39–50, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Yin, P. Hou, Z. Wu, and Y. Nie, “Decreased levels of serum omentin-1 in patients with inflammatory bowel disease,” Medical Science Monitor, vol. 21, pp. 118–122, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Roderburg, F. Benz, D. V. Cardenas et al., “Persistently elevated osteopontin serum levels predict mortality in critically ill patients,” Critical Care, vol. 19, article 271, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Singer, C. S. Deutschman, C. W. Seymour et al., “The third international consensus definitions for sepsis and septic shock (Sepsis-3),” The Journal of the American Medical Association, vol. 315, no. 8, pp. 801–810, 2016. View at Publisher · View at Google Scholar
  15. F. Tacke, C. Roderburg, F. Benz et al., “Levels of circulating mir-133a are elevated in sepsis and predict mortality in critically ill patients,” Critical Care Medicine, vol. 42, no. 5, pp. 1096–1104, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Benz, F. Tacke, M. Luedde et al., “Circulating microRNA-223 serum levels do not predict sepsis or survival in patients with critical illness,” Disease Markers, vol. 2015, Article ID 384208, 10 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Koch, E. Sanson, A. Helm, S. Voigt, C. Trautwein, and F. Tacke, “Regulation and prognostic relevance of serum ghrelin concentrations in critical illness and sepsis,” Critical Care, vol. 14, no. 3, article R94, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Koch, O. A. Gressner, E. Sanson, F. Tacke, and C. Trautwein, “Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients,” Critical Care, vol. 13, no. 3, article R95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Benz, C. Roderburg, D. Vargas Cardenas et al., “U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis,” Experimental & Molecular Medicine, vol. 45, article e42, 2013. View at Publisher · View at Google Scholar
  20. C. Roderburg, F. Benz, D. Vargas Cardenas et al., “Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases,” Liver International, vol. 35, no. 4, pp. 1172–1184, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. S. E. Siegelaar, M. Hickmann, J. B. L. Hoekstra, F. Holleman, and J. H. DeVries, “The effect of diabetes on mortality in critically ill patients: a systematic review and meta-analysis,” Critical Care, vol. 15, article R205, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. K. Badman and J. S. Flier, “The adipocyte as an active participant in energy balance and metabolism,” Gastroenterology, vol. 132, no. 6, pp. 2103–2115, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Thoonen, A. G. Hindle, and M. Scherrer-Crosbie, “Brown adipose tissue: the heat is on the heart,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 310, no. 11, pp. H1592–H1605, 2016. View at Publisher · View at Google Scholar
  24. E. Neumann, S. Junker, G. Schett, K. Frommer, and U. Müller-Ladner, “Adipokines in bone disease,” Nature Reviews Rheumatology, vol. 12, no. 5, pp. 296–302, 2016. View at Publisher · View at Google Scholar
  25. C. H. Lee, Y. C. Woo, Y. Wang, C. Y. Yeung, A. Xu, and K. S. L. Lam, “Obesity, adipokines and cancer: an update,” Clinical Endocrinology, vol. 83, no. 2, pp. 147–156, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Fenske, T. Athanasiou, L. Harling, C. Drechsler, A. Darzi, and H. Ashrafian, “Obesity-related cardiorenal disease: the benefits of bariatric surgery,” Nature Reviews Nephrology, vol. 9, no. 9, pp. 539–551, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. S. P. J. Macdonald, S. F. Stone, C. L. Neil et al., “Sustained elevation of resistin, NGAL and IL-8 are associated with severe sepsis/septic shock in the emergency department,” PLoS ONE, vol. 9, no. 10, article e110678, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. B. S. Fernandes, S. Dash, F. Jacka et al., “Leptin in bipolar disorder: a systematic review and meta-analysis,” European Psychiatry, vol. 35, pp. 1–7, 2016. View at Publisher · View at Google Scholar
  29. A. Koch, E. Sanson, S. Voigt, A. Helm, C. Trautwein, and F. Tacke, “Serum adiponectin upon admission to the intensive care unit may predict mortality in critically ill patients,” Journal of Critical Care, vol. 26, no. 2, pp. 166–174, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. Y.-L. Tan, X.-L. Zheng, and C.-K. Tang, “The protective functions of omentin in cardiovascular diseases,” Clinica Chimica Acta, vol. 448, pp. 98–106, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Schäffler, M. Neumeier, H. Herfarth, A. Fürst, J. Schölmerich, and C. Büchler, “Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue,” Biochimica et Biophysica Acta—Gene Structure and Expression, vol. 1732, no. 1–3, pp. 96–102, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. J.-K. Lee, J. Schnee, M. Pang et al., “Human homologs of the Xenopus oocyte cortical granule lectin XL35,” Glycobiology, vol. 11, no. 1, pp. 65–73, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Gerwick, G. Corley-Smith, and C. J. Bayne, “Gene transcript changes in individual rainbow trout livers following an inflammatory stimulus,” Fish and Shellfish Immunology, vol. 22, no. 3, pp. 157–171, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. J. M. Moreno-Navarrete, V. Cataln, F. Ortega et al., “Circulating omentin concentration increases after weight loss,” Nutrition and Metabolism, vol. 7, article 27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. V. Katsi, G. Vamvakou, J. Lekakis et al., “Omentin, fat and heart: classical music with new instruments,” Heart Lung and Circulation, vol. 23, no. 9, pp. 802–806, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Poirier, T. D. Giles, G. A. Bray et al., “Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 5, pp. 968–976, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. X. Zhong, X. Li, F. Liu, H. Tan, and D. Shang, “Omentin inhibits TNF-α-induced expression of adhesion molecules in endothelial cells via ERK/NF-κB pathway,” Biochemical and Biophysical Research Communications, vol. 425, no. 2, pp. 401–406, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. M. Arabi, S. I. Dara, H. M. Tamim et al., “Clinical characteristics, sepsis interventions and outcomes in the obese patients with septic shock: An International Multicenter Cohort Study,” Critical Care, vol. 17, no. 2, article R72, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. R. N. Dickerson, “The obesity paradox in the ICU: real or not?” Critical Care, vol. 17, article 154, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. S. M. A. Lobo, F. R. M. Lobo, D. P. Bota et al., “C-reactive protein levels correlate with mortality and organ failure in critically III patients,” Chest, vol. 123, no. 6, pp. 2043–2049, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Boussekey, O. Leroy, H. Georges, P. Devos, T. d'Escrivan, and B. Guery, “Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit,” Infection, vol. 33, no. 4, pp. 257–263, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. D. M. Griffith, M. E. Vale, C. Campbell, S. Lewis, and T. S. Walsh, “Persistent inflammation and recovery after intensive care: a systematic review,” Journal of Critical Care, vol. 33, pp. 192–199, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Akba, S. Karakurt, G. Nlgzel, T. Çelikel, and S. Akalin, “The endocrinologic changes in critically ill chronic obstructive pulmonary disease patients,” COPD, vol. 7, no. 4, pp. 240–247, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. S. S. Gülcher, N. A. Bruins, W. P. Kingma, and E. C. Boerma, “Elevated C-reactive protein levels at ICU discharge as a predictor of ICU outcome: a retrospective cohort study,” Annals of Intensive Care, vol. 6, article 5, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. J.-L. Vincent, J.-C. Preiser, C. L. Sprung, R. Moreno, and Y. Sakr, “Insulin-treated diabetes is not associated with increased mortality in critically ill patients,” Critical Care, vol. 14, no. 1, article R12, 2010. View at Publisher · View at Google Scholar · View at Scopus